Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

v-SNARE Vti1p Inhibitors

The chemical class known as v-SNARE Vti1p Inhibitors is characterized by its ability to target and modulate the activity of the Vti1p protein, which is a key component of the vesicular SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex. Vti1p, a v-SNARE protein, plays a crucial role in the process of vesicle fusion within cellular membranes. The inhibitors in this class are specifically designed to interact with Vti1p and disrupt its function in vesicular trafficking. Structurally, these inhibitors are diverse but generally share common features that enable them to bind to Vti1p. They often contain core motifs that complement the protein's binding site, such as hydrophobic regions, aromatic systems, and sometimes specific peptide-like sequences.

The synthesis of v-SNARE Vti1p inhibitors involves advanced chemical techniques to ensure specificity and potency. This typically includes the design of molecular frameworks that can specifically recognize and bind to the Vti1p protein. The chemical class employs a range of organic synthesis methods, including combinatorial chemistry to generate a library of potential inhibitors, which are then screened for their ability to interact with Vti1p. High-throughput screening and molecular modeling are often utilized to refine these compounds, optimizing their binding affinity and functional efficacy. The detailed structural characteristics of these inhibitors, such as their ability to engage in hydrogen bonding, hydrophobic interactions, and other non-covalent interactions with Vti1p, are critical for understanding their mechanism of action and effectiveness in disrupting the vesicular transport processes mediated by Vti1p.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits protein synthesis in eukaryotic organisms, potentially reducing the production of Vti1p.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Binds to DNA and disrupts RNA synthesis by RNA polymerase, potentially decreasing Vti1p transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that can alter gene expression patterns, potentially affecting Vti1p expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor, it can modify chromatin structure and affect gene expression, including that of Vti1p.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Inhibits DNA methylation, which might change the methylation status and expression of Vti1p.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Causes premature termination of protein synthesis, potentially reducing Vti1p levels.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Inhibits RNA polymerase II, potentially reducing the transcription of Vti1p.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that could block the degradation of proteins, potentially affecting Vti1p turnover.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

As a histone deacetylase inhibitor, it may influence the expression of genes such as Vti1p.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts ER-to-Golgi transport, potentially affecting the trafficking and expression of SNARE proteins like Vti1p.